European Morning Report: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on European Morning Report.

Press releases published on June 3, 2026

Jun. 3, 2026

Krytheon Advances Human-Centric Governance for Regulated AI Execution

Indeterminate EIN Presswire

Jun. 3, 2026

Xcube.bio Strengthens Board with Appointment of Three Distinguished Non-Executive Directors

Indeterminate GlobeNewswire

Jun. 3, 2026

NewAmsterdam Pharma Announces Upcoming Presentations at the National Lipid Association (NLA) 2026 Scientific Sessions

Indeterminate GlobeNewswire

Jun. 3, 2026

SOTIO Receives U.S. FDA Orphan Drug Designation for SOT106, a Potential Best-in-Class ADC for Sarcoma

Indeterminate GlobeNewswire

Jun. 3, 2026

Kyverna Therapeutics Highlights Updated Miv-cel Data at EULAR Demonstrating Substantial Reduction in Disease Activity in ACPA-Positive, Treatment Refractory Rheumatoid Arthritis

Indeterminate GlobeNewswire

Jun. 3, 2026

Terra Balcanica Obtains Exploration Licence in Bosnia-Herzegovina

Indeterminate GlobeNewswire

Jun. 3, 2026

Angelini Ventures Marks First Portfolio Company Exit as ResMed Acquires Noctrix Health for $340 million

Indeterminate GlobeNewswire

Jun. 3, 2026

Koryx Copper Provides Project Development Update for the Haib Copper Project in Southern Namibia

Indeterminate GlobeNewswire

Jun. 3, 2026

Virtune AB (Publ) ("Virtune") has completed the monthly rebalancing for May 2026 of its Virtune Crypto Top 10 Index ETP - the first crypto index ETP in the Nordics

Indeterminate GlobeNewswire

Jun. 3, 2026

Virtune AB (Publ) (“Virtune”) har genomfört den månatliga rebalanseringen för maj 2026 av Virtune Crypto Top 10 Index ETP, Nordens första kryptoindex-ETP

Indeterminate GlobeNewswire

Jun. 3, 2026

Invivyd Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Indeterminate GlobeNewswire

Jun. 3, 2026

79% of Enterprises Are Confident They Can Scale AI Without Breaking Governance. Only 29% Can Even Find the Data.

Indeterminate GlobeNewswire

Jun. 3, 2026

Cabaletta Bio Announces New Rese-cel Data and Development Updates Across Autoimmune Portfolio, Including Encouraging Early PC-Free Lupus Findings, at EULAR 2026 Congress

Indeterminate GlobeNewswire

Jun. 3, 2026

Cocrystal Pharma Appoints James Sapirstein, Biopharma Industry Leader with Extensive Antiviral Development Experience, as Chief Executive Officer

Indeterminate GlobeNewswire

Jun. 3, 2026

Emerita Announces Appointments of New Independent Director and Corporate Secretary

Indeterminate GlobeNewswire

Jun. 3, 2026

Highland Copper Identifies Key Optimization Opportunities Through Detailed Engineering at the Copperwood Project

Indeterminate GlobeNewswire

Jun. 3, 2026

Avalyn Reports First Quarter 2026 Financial Results and Recent Business Highlights

Indeterminate GlobeNewswire

Jun. 3, 2026

Tenaya Therapeutics Announces Interim Data from MyPEAK™-1 Showing Treatment of MYBPC3-associated HCM with TN-201 Gene Therapy Resulted in Consistent Signs of Cardiac Remodeling and Reductions in Symptoms

Indeterminate GlobeNewswire

Jun. 3, 2026

Dark Horse Consulting Group and Altruist Biologics Announce Memorandum of Understanding to Advance Biologics Manufacturing and Development in China

Indeterminate GlobeNewswire

Jun. 3, 2026

Medicenna’s MDNA11 Potential in Earlier Line Melanoma Setting Highlighted in Presentation of the NEO-CYT trial at ASCO 2026

Indeterminate GlobeNewswire